Gyon Technologies Capital Management’s Biogen BIIB Stock Holding History

Gyon Technologies Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-791	Closed	-$211K	–	493
2022 Q3	$211K	Sell	791 -1,371	-63%	-$291K	0.07%	323
2022 Q2	$441K	Buy	+2,162	New	+$442K	0.12%	192
2022 Q1	–	Sell	-1,837	Closed	-$441K	–	295
2021 Q4	$441K	Buy	+1,837	New	+$472K	0.08%	336
2021 Q3	–	Sell	-8,458	Closed	-$2.93M	–	376
2021 Q2	$2.93M	Buy	8,458 +7,401	+700%	+$2.24M	0.96%	9
2021 Q1	$296K	Sell	1,057 -1,535	-59%	-$414K	0.13%	276
2020 Q4	$635K	Buy	2,592 +440	+20%	+$114K	0.22%	143
2020 Q3	$610K	Buy	+2,152	New	+$600K	0.48%	71
2020 Q1	–	Sell	-2,428	Closed	-$720K	–	111
2019 Q4	$720K	Buy	+2,428	New	+$674K	0.48%	68

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Gyon Technologies Capital Management's BIIB Position: Q4 2022 in Review

Gyon Technologies Capital Management sold out of Biogen (BIIB) in Q4 2022, closing a stake of 791 shares — an estimated $211K sold.

Gyon Technologies Capital Management first reported a position in BIIB in Q4 2019 and held it in 8 quarters. The position peaked at $2.93M in Q2 2021. 1,032 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.

Gyon Technologies Capital Management reported no remaining Biogen position as of Q4 2022 after selling out during the quarter.
Gyon Technologies Capital Management sold 791 Biogen shares in Q4 2022, an estimated $211K.
Gyon Technologies Capital Management first reported a position in Biogen in Q4 2019 and held it in 8 quarters.
Gyon Technologies Capital Management's Biogen position peaked at $2.93M in Q2 2021.
1,032 funds tracked by Wall St. Rank held Biogen as of Q4 2022.

Based on Gyon Technologies Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.